Far Infrared Treatment for Alzheimer's Disease

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages Any age
• All sexes
• No healthy volunteers
• Child, Adult, Older adult

Trial locations and contacts

1 site in 1 country.

About this study

Official title: Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Treatment of Alzheimer's Disease.

Conditions

Alzheimer Disease

Being tested

Far Infrared Radiation (5μm to 20μm wavelength)

Keywords

Acute Confusional Senile Dementia, Alzheimer Type Senile Dementia, SENILE PLAQUES, NEUROFIBRILLARY TANGLES, NEUROPIL THREADS

Medical subject headings

Alzheimer Disease, Plaque, Amyloid

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Far Infrared Radiation (5μm to 20μm wavelength)Radiation

  Far Infrared radiation for 30 to 40 minutes per treatment session.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Management and Cure of Alzheimer's Disease

   Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted23 Jan 2008 (estimated)
2. Study startFeb 2008
3. Primary completionMar 2009 (estimated)
4. Study completionApr 2009 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Alzheimer DiseaseStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.